
Why One Drug Company Held Back a Better Drug
The Daily
00:00
The Controversy of Withheld Innovations in Drug Development
This chapter examines the ethical implications of a pharmaceutical company's decision to withhold a safer medication in the pursuit of profit. It highlights internal documents that reveal the executives' thought processes related to FDA approval and the development of a potentially improved drug.
Transcript
Play full episode